Estrella Immunopharma, Inc. (ESLA): NT 10-Q filed May 18, 2026

Form type

NT 10-Q

Filing date

May 18, 2026

Accession number

0001213900-26-058062

Filer

Estrella Immunopharma, Inc. (CIK 1844417)